Not exact matches
And herein lies a very broad and «mushy middle,» says McKenna, with the
effect, in many cases, being the same: «It's still using smaller -
than -
treatment doses, or sub-therapeutic doses of antibiotics,» which creates a literal breeding ground for resistant microbial strains.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger
than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in
treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the
effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Dog owners find it more effective
than other topical flea
treatments, and they say side
effects are rare.
Although some doctors do use it as part of
treatment, it often carries riskier side
effects than what you want to treat.
Abiraterone, approved in 2011 for the
treatment of metastatic prostate cancer, has a «food
effect» that is greater
than any other marketed drug.
They found that the synthetic odors mimicked the
effect of the presence of a live queen in a nest — fewer workers» ovaries were activated and more regressed when exposed to the odor
treatment than in non-odor controls.
No major toxic
effects were observed, and the patient «was able to survive a much longer period
than expected with an improved quality of life, which is clearly attributable to the
treatment with 3BP,» the scientists concluded.
Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side
effects five years after
treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet.
A non-hormonal option for male contraception is preferable to hormonal
treatments currently in clinical trials, because the types of hormones that make men infertile have more severe side
effects than those used in the female pill.
Researchers at New York Eye and Ear Infirmary of Mount Sinai showed that a microdose delivery system achieved a
treatment effect comparable to a conventional eyedropper, while delivering less
than four times the amount of drug.
Since children of mothers with preclinical RA also had an increased risk of epilepsy, Rom said the findings point towards an important role of the disease itself rather
than an
effect of
treatments for RA.
Originally offered as a radical
treatment for severe obesity, the surgery's
effects on the digestive system and metabolism have turned out to be far more mysterious and fascinating
than anyone expected.
«If they progress more slowly
than usual within that time frame, that would suggest these
treatments are having their desired
effect.»
Instead, researchers told the European Breast Cancer Conference that their findings suggest that extending screening programs to older women results in a large proportion of women being over-treated, and at risk from the harmful
effects of such
treatment, because these women were more likely to die from other causes
than from any tumors detected in the early stages of growth.
At this stage, the aims of the trials would be modest, seeking only to assess whether the
treatments have a measurable
effect, rather
than expecting dramatic clinical improvement of the patients» condition.
In the lab, the antibiotics had no harmful
effect on normal cells, and since they are already approved for use in humans, trials of new
treatments should be simpler
than with new drugs — saving time and money.
The conclusion: Ginkgo biloba «appears to be a safe and effective alternative to the current therapeutic alternatives for the
treatment of dementia» and has fewer side
effects than Tacrine, a popular prescription medicine for the condition.
Some of these patients are likely to experience more adverse side -
effects and complications from the
treatment than from the cancer itself.
To explain why antidepressants in such trials nevertheless often cause greater symptom relief
than placebo, it has been suggested that SSRI - induced side
effects will make the patient understand that he or she has not been given placebo, hence enhancing his or her belief of having been given an effective
treatment.
By combining this inhibition of FAK with radiotherapy, the group was able to achieve a greater
treatment effect than with either therapy alone.
Thus, so far, it has never been investigated whether individuals in clinical trials experiencing side
effects from antidepressant medication, and for this reason may have guessed that they have not received placebo, also respond more favorably to
treatment than those without side
effects.
«So the exact mechanisms behind the observed increase in risk are still unknown,» explained Dr Jensen, «but it is generally believed that underlying infertility has a more important role in adverse
effects in the offspring
than the
treatment procedures.
The
effect of hormone
treatments on bone mineral density (BMD) is another issue for spaceflight, where astronauts lose bone at a much higher rate
than on Earth.
Six months prior, the U.S. Food & Drug Administration (FDA) approved sofosbuvir, an oral medication shown to cure most cases of hepatitis C infection, with fewer side
effects than the current
treatment options.
The study is investigator led and has therefore focused on clinical need, targeting patients with progressive multiple sclerosis in whom most disability is incurred... The study also reports a predominant
effect on neurodegenerative rather
than inflammatory outcomes, suggesting a novel mechanism of action that might be suitable as combination
treatment with immunomodulatory
treatments... Further phase 3 studies to measure the
effect of simvastatin on sustained disability, particularly in patients with non-relapsing secondary progressive and primary progressive multiple sclerosis, are clearly needed, but this trial represents a promising point from which to develop trials of progressive disease.»
The latter investigations may inflate a
treatment's
effects even more
than online patient reviews do, Ioannidis asserts.
«Identifying a cancer driver is crucial for cancer
treatment because it allows the use of targeted therapies, which have less side -
effects than conventional chemotherapy drugs, against a particular protein,» said Kurokawa.
They hypothesized that excess brain dopamine release in heavy alcohol users who also use nicotine / smoke could make them more
treatment - resistant in general, but more sensitized to naltrexone's dopamine lowering
effects — leading to their greater response to
treatment with the medication
than non-smokers.
Such a
treatment in humans, Glick says, might have fewer side
effects than the immune - suppression drugs currently used to treat the condition.
The
treatment is associated with side
effects so doctors do not treat patients longer
than necessary.
Clinical trials of weight loss have been shown to improve participants» mood, but this could be a result of the supportive environment rather
than the weight loss itself, as the
effects are seen very early on in
treatment and are not related to the extent of weight loss.
The
effect of physiotherapy alone was no better
than watchful waiting (no
treatment).
The authors noted that low croploads during the study period may also have contributed to reduced
effects of
treatments on cherry quality characteristics other
than size.
Though behavioral parent training is known to have positive results for children with ADHD, fewer parents and mental health and medical practitioners know about it
than medication prescribed for ADHD, which can come with side
effects and is not recommended as a first - line
treatment for preschool - age children, DuPaul said.
A move to lengthen limbs internally rather
than via an external scaffold could reduce the
effects of painful
treatments, especially among younger patients
This result implies that only large
treatment effects can be detected by efficacy studies in hAPP mice, since the number of mice per group will likely not be greater
than 50, for practical and ethical reasons.
The
effect of glucocorticoid
treatment is most prominent on trabecular bone and is therefore likely to be larger on vertebral bone
than on hip bone.3 Glucocorticoids are associated with an increased rate of fracture, and higher doses and longer use of glucocorticoids are associated with higher risks of fracture.4 Compared with patients not taking glucocorticoids, the risk of hip and vertebral fracture among patients taking glucocorticoids is increased by 60 % and 160 %, respectively.4 Among 80 - year - old patients, the hip fracture risk is increased by a magnitude of 2.1 and is independent of BMD.5 Most studies indicate that fracture risk is increased following at least 3 months of
treatment with daily doses of 5 mg of prednisolone or more in older men and women.4
Understanding this interaction will lead to targeted
treatment «block the interaction» rather
than the non-specific dampening of inflammation such as by corticosteroids with its many well - documented side
effects and limited efficacy.»
Blacks were more likely to think their cancer was not aggressive and were more likely to worry about the
treatment's cost and side
effects than their white counterparts.
In particular, it is crucial to find out whether this is associated with the timing of the
treatment or possible side
effects of it rather
than the stem cell transplant itself.
The failure in pancreatic cancer
treatment is main due to the presence of a dense and poorly vascularized stroma that increase the drug clearance in the tumors rather
than the healthy tissues, decreasing drug bioavailability in the target tissue and leading to significant side
effects.
There are a wide range of therapeutic
treatments [1], although none have shown any more
than modest clinical
effects [2].
The whole animal studies suggest that the experimental drug could have fewer side -
effects than current
treatments.
Because of the early stage of the trials, more work is needed to see «if the vaccines are better
than existing
treatments, if they improve survival, and what their long - term side
effects could be.»
The team's work may pave the way for obesity
treatments with fewer side
effects than current medications and negate the need for invasive surgeries.
The system was shown to work nearly as well as — or in some cases better
than — when the drug was freely moving, the type of scenario that causes the commonly experienced cancer
treatment side
effects.
Synergy between drugs occurs when the result of
treatment with both together is more dramatic
than would be expected by adding the two
effects.
But she warned that the net
effects could be more detrimental
than beneficial, too, so any such potential
treatment would need to be tested carefully.
The therapy, which is described the week of February 13, 2017, in Proceedings of the National Academy of Sciences, can be effective longer and likely has fewer side
effects than existing
treatments, and could be produced much more cheaply.
Treatment takes less
than a second and does not have any known side
effects.